{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:18:53Z","timestamp":1783113533470,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["2508"],"award-info":[{"award-number":["2508"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virol.2026.110957","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:15:13Z","timestamp":1778969713000},"page":"110957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The rotavirus cVLPVP8\u2217 vaccine candidate induces cross-genotype\/heterotypic neutralizing antibody responses against human rotavirus G9P[4]"],"prefix":"10.1016","volume":"621","author":[{"given":"Farzane","family":"Behnezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angila","family":"Ataei-Pirkooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Kachooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Golsaz-Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Arashkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Mir-Hosseinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh-Sadat","family":"Hosseini-Fakhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Mousavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Jalilvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Roohvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-5844","authenticated-orcid":false,"given":"Zabihollah","family":"Shoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.110957_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.coviro.2012.05.003","article-title":"Rotavirus immune responses and correlates of protection","volume":"2","author":"Angel","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2026.110957_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110957_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/erv.13.3","article-title":"Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease","volume":"12","author":"Azevedo","year":"2013","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib4","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110957_bib5","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110957_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mi.2012.51","article-title":"IgA is important for clearance and critical for protection from rotavirus infection","volume":"5","author":"Blutt","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.virol.2026.110957_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2026.110957_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.272.5258.104","article-title":"Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity","volume":"272","author":"Burns","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virol.2026.110957_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1954","article-title":"Rotavirus virus\u2010like particles (RV\u2010VLPs) vaccines: an update","volume":"27","author":"Changotra","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2026.110957_bib10","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1016\/j.vaccine.2021.04.060","article-title":"Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC\u00ae and ROTAVAC 5D\u00ae in Zambian infants","volume":"39","author":"Chilengi","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2023.10.005","article-title":"Estimating the global impact of rotavirus vaccines on child mortality","volume":"137","author":"Clark","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110957_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/emboj\/21.5.885","article-title":"The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site","volume":"21","author":"Dormitzer","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2026.110957_bib13","first-page":"320","article-title":"Multicentral study of rotavirus infection, diversity of circulating genotypes and clinical outcomes in children\u2264 5 years old in Iran","volume":"43","author":"Fallah","year":"2023","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virol.2026.110957_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1473-3099(20)30001-3","article-title":"Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Groome","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2026.110957_bib15","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI44262","article-title":"Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice","volume":"121","author":"Hammerschmidt","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virol.2026.110957_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015","volume":"388","author":"Hay","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110957_bib17","series-title":"Hsiung\u2019s Diagnostic Virology: as Illustrated by Light and Electron Microscopy","author":"Hsiung","year":"1994"},{"key":"10.1016\/j.virol.2026.110957_bib18","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2015.05.026","article-title":"Rotavirus VP6 preparations as a non-replicating vaccine candidates","volume":"33","author":"Jalilvand","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110695","article-title":"Isolation, propagation, and characterization of a G9P","author":"Kachooei","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110957_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28529","article-title":"Molecular characterization of rotavirus infections in children less than 5 years of age with acute gastroenteritis in Tehran, Iran, 2021\u20132022: emergence of uncommon G9P [4] and G9P [8] rotavirus strains","volume":"95","author":"Kachooei","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2026.110957_bib21","article-title":"Global epidemiology of vaccine-associated intussusception in children and adolescents, 1968 to 2024: an international pharmacovigilance study","volume":"104","author":"Kim","year":"2025","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.virol.2026.110957_bib22","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072788","article-title":"Global causes of diarrheal disease mortality in children< 5 years of age: a systematic review","volume":"8","author":"Lanata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110957_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2023.109903","article-title":"Characterization and immunogenicity of a novel chimeric hepatitis B core-virus like particles (cVLPs) carrying rotavirus VP8\u2217 protein in mice model","volume":"588","author":"Latifi","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110957_bib25","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1128\/JVI.00979-12","article-title":"Rotavirus VP8\u2217: phylogeny, host range, and interaction with histo-blood group antigens","volume":"86","author":"Liu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110957_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/v16020211","article-title":"Safety, immunogenicity, and mechanism of a rotavirus mRNA-LNP vaccine in mice","volume":"16","author":"Lu","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110957_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110957_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cimid.2007.07.005","article-title":"Rotavirus gastroenteritis: why to back up the development of new vaccines?","volume":"31","author":"Parez","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110957_bib29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virol.2026.110957_bib30","article-title":"Short or long interval between priming and boosting: does it impact on the vaccine immunogenicity?","volume":"9","author":"Pettini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110957_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41541-023-00790-z","article-title":"mRNA-based VP8\u2217 nanoparticle vaccines against rotavirus are highly immunogenic in rodents","volume":"8","author":"Roier","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virol.2026.110957_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110957_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7774\/cevr.2021.10.3.203","article-title":"Parenteral, non-live rotavirus vaccine: recent history and future perspective","volume":"10","author":"Song","year":"2021","journal-title":"Clin. Experim. Vacc. Res."},{"key":"10.1016\/j.virol.2026.110957_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0952-7915(96)80058-6","article-title":"Immunoglobulin class switching","volume":"8","author":"Stavnezer","year":"1996","journal-title":"Curr. Opin. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2026.110957_bib35","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2026.110957_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1679081","article-title":"Global trends, inequalities, and pathogen shifts in infectious diarrhea among children under five: a comprehensive analysis of the global burden of disease study 1990-2021","volume":"12","author":"Tian","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.virol.2026.110957_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.virol.2026.110957_bib38","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.vaccine.2006.03.025","article-title":"Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants","volume":"24","author":"Vesikari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human\u2013bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110957_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/TCRM.S821","article-title":"Why does the world need another rotavirus vaccine?","volume":"4","author":"Ward","year":"2008","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.virol.2026.110957_bib41","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1080\/21645515.2015.1054583","article-title":"Tandem truncated rotavirus VP8\u2217 subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic","volume":"11","author":"Wen","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.110957_bib42","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1016\/j.vaccine.2012.07.078","article-title":"Construction and characterization of human rotavirus recombinant VP8\u2217 subunit parenteral vaccine candidates","volume":"30","author":"Wen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib43","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1016\/j.vaccine.2014.06.060","article-title":"Inclusion of a universal tetanus toxoid CD4+ T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus \u0394VP8\u2217 subunit parenteral vaccines","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib44","series-title":"Open Forum Infectious Diseases","first-page":"ofy292","article-title":"Effectiveness of the oral human attenuated rotavirus vaccine: a systematic review and meta-analysis\u20142006\u20132016","author":"Willame","year":"2018"},{"key":"10.1016\/j.virol.2026.110957_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.12998\/wjcc.v6.i11.426","article-title":"Isolation and characterization of a new candidate human inactivated rotavirus vaccine strain from hospitalized children in Yunnan, China: 2010-2013","volume":"6","author":"Wu","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.virol.2026.110957_bib46","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2019.05.075","article-title":"Immune response and protective efficacy of the S particle presented rotavirus VP8\u2217 vaccine in mice","volume":"37","author":"Xia","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/v13010072","article-title":"A nanoparticle-based trivalent vaccine targeting the glycan binding VP8\u2217 domains of rotaviruses","volume":"13","author":"Xia","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110957_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1557415","article-title":"The recent advances in vaccine adjuvants","volume":"16","author":"Xing","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110957_bib49","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.vaccine.2015.03.068","article-title":"Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate","volume":"33","author":"Xue","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110957_bib50","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1080\/21645515.2016.1204501","article-title":"Immunogenicity and protective efficacy of rotavirus VP8\u2217 fused to cholera toxin B subunit in a mouse model","volume":"12","author":"Xue","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.110957_bib51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JCM.05590-11","article-title":"Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in rotarix and RotaTeq","volume":"50","author":"Zeller","year":"2012","journal-title":"J. Clin. Microbiol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:37:51Z","timestamp":1783111071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S0042682226001728"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110957","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rotavirus cVLPVP8\u2217 vaccine candidate induces cross-genotype\/heterotypic neutralizing antibody responses against human rotavirus G9P[4]","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110957"}}